Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Assets Average (2021 - 2025)

Historic Assets Average for Biofrontera (BFRI) over the last 5 years, with Q3 2025 value amounting to $17.8 million.

  • Biofrontera's Assets Average fell 1130.71% to $17.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.8 million, marking a year-over-year decrease of 1130.71%. This contributed to the annual value of $25.0 million for FY2024, which is 3651.92% down from last year.
  • Biofrontera's Assets Average amounted to $17.8 million in Q3 2025, which was down 1130.71% from $18.4 million recorded in Q2 2025.
  • Biofrontera's Assets Average's 5-year high stood at $54.3 million during Q3 2022, with a 5-year trough of $17.8 million in Q3 2025.
  • Over the past 5 years, Biofrontera's median Assets Average value was $28.6 million (recorded in 2023), while the average stood at $33.3 million.
  • Its Assets Average has fluctuated over the past 5 years, first surged by 5449.67% in 2022, then tumbled by 4344.9% in 2024.
  • Biofrontera's Assets Average (Quarter) stood at $34.3 million in 2021, then soared by 54.5% to $53.0 million in 2022, then plummeted by 41.44% to $31.0 million in 2023, then plummeted by 34.53% to $20.3 million in 2024, then fell by 12.46% to $17.8 million in 2025.
  • Its Assets Average stands at $17.8 million for Q3 2025, versus $18.4 million for Q2 2025 and $19.3 million for Q1 2025.